MYMD MyMD Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: MYMD

Price (delayed)

$3.3

Market cap

$7.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.33

Enterprise value

$4.49M

Highlights
The company's net income has surged by 74% YoY and by 26% QoQ
The company's debt has shrunk by 66% YoY and by 48% QoQ
The quick ratio fell by 43% YoY and by 34% QoQ
MyMD Pharmaceuticals's equity has decreased by 20% QoQ and by 16% YoY
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: https://ir.mymd.com/
Peers: OMER OMGA

Key stats

What are the main financial stats of MYMD
Market
Shares outstanding
2.16M
Market cap
$7.12M
Enterprise value
$4.49M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.45
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$4M
EBITDA
-$4M
Free cash flow
-$12.98M
Per share
EPS
-$5.33
Free cash flow per share
-$8.42
Book value per share
$7.29
Revenue per share
$0
TBVPS
$4.77
Balance sheet
Total assets
$17.86M
Total liabilities
$5.09M
Debt
$48,870
Equity
$12.37M
Working capital
$828,253
Liquidity
Debt to equity
0
Current ratio
1.17
Quick ratio
0.99
Net debt/EBITDA
0.66
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-35.2%
Return on equity
-63.6%
Return on invested capital
-47.4%
Return on capital employed
-31.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MYMD stock price

How has the MyMD Pharmaceuticals stock price performed over time
Intraday
1.85%
1 week
17.02%
1 month
46.67%
1 year
-93.99%
YTD
-57.48%
QTD
38.08%

Financial performance

How have MyMD Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$16.36M
Net income
-$4M
Gross margin
N/A
Net margin
N/A
The company's net income has surged by 74% YoY and by 26% QoQ
MYMD's operating income is down by 7% since the previous quarter and by 7% year-on-year

Growth

What is MyMD Pharmaceuticals's growth rate over time

Valuation

What is MyMD Pharmaceuticals stock price valuation
P/E
N/A
P/B
0.45
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has soared by 55% YoY and by 2% from the previous quarter
The stock's P/B is 89% below its 5-year quarterly average of 4.0 and 87% below its last 4 quarters average of 3.4
MyMD Pharmaceuticals's equity has decreased by 20% QoQ and by 16% YoY

Efficiency

How efficient is MyMD Pharmaceuticals business performance
MYMD's ROIC has soared by 81% year-on-year and by 17% since the previous quarter
The ROA has soared by 54% YoY but it has contracted by 16% from the previous quarter
MyMD Pharmaceuticals's return on equity has increased by 28% YoY but it has decreased by 21% QoQ

Dividends

What is MYMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MYMD.

Financial health

How did MyMD Pharmaceuticals financials performed over time
The total liabilities has soared by 79% YoY but it has decreased by 11% QoQ
The quick ratio fell by 43% YoY and by 34% QoQ
The company's debt is 100% lower than its equity
The debt to equity has dropped by 100% since the previous quarter and by 100% year-on-year
The company's debt has shrunk by 66% YoY and by 48% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.